Activation of murine macrophages by tumor necrosis factor, interleukin-1, interferon-γ and cisplatin

Ajit Sodhi, Rakesh Kumar Singh, Kalpana Pai

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Murine peritoneal macrophages were rendered tumoricidal to Dalton's lymphoma (DL) cells on incubation with recombinant tumor necrosis factor alpha (rTNF-α), recombinant interleukin-1 (rIL-1) and cisplatin in vitro. Simultaneous treatment of macrophages with suboptimal doses of rTNF-α and rIL-1 had additive effect on the activation of macrophages. Priming of macrophages with recombinant interferon gamma (rIFN-γ) significantly enhanced the rTNF-α and rIL-1-induced macrophage cytotoxicity. Cisplatin was found to up-regulate rIL-1-induced macrophage activation but inhibited the activation of macrophages with rTNF-α. These studies indicate the potential of appropriate combination of these Biological Response Modifiers (BRMs) against neoplasia.

Original languageEnglish (US)
Pages (from-to)45-50
Number of pages6
JournalImmunology Letters
Volume26
Issue number1
DOIs
StatePublished - Oct 1990

Fingerprint

Macrophage Activation
Interleukin-1
Interferons
Cisplatin
Tumor Necrosis Factor-alpha
Macrophages
Immunologic Factors
Peritoneal Macrophages
Interferon-gamma
Lymphoma
Up-Regulation
Neoplasms

Keywords

  • Cisplatin
  • Interferon-γ
  • Interleukin-1
  • Macrophage
  • Tumor necrosis factor

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Activation of murine macrophages by tumor necrosis factor, interleukin-1, interferon-γ and cisplatin. / Sodhi, Ajit; Kumar Singh, Rakesh; Pai, Kalpana.

In: Immunology Letters, Vol. 26, No. 1, 10.1990, p. 45-50.

Research output: Contribution to journalArticle

@article{247cd13bd064463d91195db5e90670f1,
title = "Activation of murine macrophages by tumor necrosis factor, interleukin-1, interferon-γ and cisplatin",
abstract = "Murine peritoneal macrophages were rendered tumoricidal to Dalton's lymphoma (DL) cells on incubation with recombinant tumor necrosis factor alpha (rTNF-α), recombinant interleukin-1 (rIL-1) and cisplatin in vitro. Simultaneous treatment of macrophages with suboptimal doses of rTNF-α and rIL-1 had additive effect on the activation of macrophages. Priming of macrophages with recombinant interferon gamma (rIFN-γ) significantly enhanced the rTNF-α and rIL-1-induced macrophage cytotoxicity. Cisplatin was found to up-regulate rIL-1-induced macrophage activation but inhibited the activation of macrophages with rTNF-α. These studies indicate the potential of appropriate combination of these Biological Response Modifiers (BRMs) against neoplasia.",
keywords = "Cisplatin, Interferon-γ, Interleukin-1, Macrophage, Tumor necrosis factor",
author = "Ajit Sodhi and {Kumar Singh}, Rakesh and Kalpana Pai",
year = "1990",
month = "10",
doi = "10.1016/0165-2478(90)90174-O",
language = "English (US)",
volume = "26",
pages = "45--50",
journal = "Immunology Letters",
issn = "0165-2478",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Activation of murine macrophages by tumor necrosis factor, interleukin-1, interferon-γ and cisplatin

AU - Sodhi, Ajit

AU - Kumar Singh, Rakesh

AU - Pai, Kalpana

PY - 1990/10

Y1 - 1990/10

N2 - Murine peritoneal macrophages were rendered tumoricidal to Dalton's lymphoma (DL) cells on incubation with recombinant tumor necrosis factor alpha (rTNF-α), recombinant interleukin-1 (rIL-1) and cisplatin in vitro. Simultaneous treatment of macrophages with suboptimal doses of rTNF-α and rIL-1 had additive effect on the activation of macrophages. Priming of macrophages with recombinant interferon gamma (rIFN-γ) significantly enhanced the rTNF-α and rIL-1-induced macrophage cytotoxicity. Cisplatin was found to up-regulate rIL-1-induced macrophage activation but inhibited the activation of macrophages with rTNF-α. These studies indicate the potential of appropriate combination of these Biological Response Modifiers (BRMs) against neoplasia.

AB - Murine peritoneal macrophages were rendered tumoricidal to Dalton's lymphoma (DL) cells on incubation with recombinant tumor necrosis factor alpha (rTNF-α), recombinant interleukin-1 (rIL-1) and cisplatin in vitro. Simultaneous treatment of macrophages with suboptimal doses of rTNF-α and rIL-1 had additive effect on the activation of macrophages. Priming of macrophages with recombinant interferon gamma (rIFN-γ) significantly enhanced the rTNF-α and rIL-1-induced macrophage cytotoxicity. Cisplatin was found to up-regulate rIL-1-induced macrophage activation but inhibited the activation of macrophages with rTNF-α. These studies indicate the potential of appropriate combination of these Biological Response Modifiers (BRMs) against neoplasia.

KW - Cisplatin

KW - Interferon-γ

KW - Interleukin-1

KW - Macrophage

KW - Tumor necrosis factor

UR - http://www.scopus.com/inward/record.url?scp=0025031798&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025031798&partnerID=8YFLogxK

U2 - 10.1016/0165-2478(90)90174-O

DO - 10.1016/0165-2478(90)90174-O

M3 - Article

C2 - 2125975

AN - SCOPUS:0025031798

VL - 26

SP - 45

EP - 50

JO - Immunology Letters

JF - Immunology Letters

SN - 0165-2478

IS - 1

ER -